12.12.24 -- Streamline Data Collection and Enhance Data Quality

eCOA solutions enhance data quality in clinical trials by preventing common issues in paper-based COA data, such as missing, ambiguous, or conflicting entries, and ensuring reliable data collection.

Join our speakers as they explore the future of digital data in clinical trials and consider whether the industry is ready to move beyond traditional EDC models.

This study challenges the commonly applied exclusionary approach to clinical trials, particularly cancer trials, that underrepresent certain populations and limit the generalizability of research advancements.

Dive into the insights from our recent LinkedIn Live discussion where we explored how a standardized approach to eCOA could transform clinical trials and streamline data collection.

While RTSM systems help reduce many of the risks in clinical trials, each trial’s unique setup necessitates a risk analysis to identify trial-specific challenges.

As the industry landscape shifts with the rise of generic and biosimilar drugs, pharmaceutical companies are relying on robust data analytics to inform decision-making across the product lifecycle.

Industry experts share their perspectives on end-to-end clinical development, essential elements of a unified clinical platform, as well as the associated benefits and challenges involved.

In this webinar, explore the importance of eCOAs, how they have evolved from the standard paper diaries, and what efficiencies you can realize from them.